reduktan
leros spol.s r.o., Česká republika - iné liečivá - 94 - fytopharmaca
testy ivd focus diagn. - zoznam2/b,
focus diagnostika 10703 progress way 90630 cypress, ca spojené štáty americké -
benlysta
glaxosmithkline (ireland) limited - belimumab - lupus erythematosus, systémový - imunosupresíva - benlysta je indikovaný ako prídavná terapia u pacientov vo veku od 5 rokov a starších s aktívnym, autoantibody pozitívne systémový lupus erythematosus (sle) s vysokým stupňom aktivity ochorenia (e. pozitívne anti-dsdna a nízke dopĺňať), napriek tomu, štandardná terapia. benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.
saphnelo
astrazeneca ab - anifrolumab - lupus erythematosus, systémový - imunosupresíva - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.
lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - imunosupresíva - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).